Loading...

EKSO EKSO BIONICS HOLDINGS INC Capital Structure Changes 8-K Filing

KS B

KS

EKSO BIONICS HOLDINGS INC

(EKSO)

2025 8-K

Summary

Summary

Loan Agreement Secured

Financial Statements

Reverse Stock Split

Financial Statements

Warrant Agreement

Financial Results

Q4 2024 Results

Nasdaq Compliance Notice

Financial Results

Public Offering

Financial Results

Amendment to Initial 8-K

Annual Meeting of Stockholders

Financial Results

Financial Results Announcement

Securities Purchase Agreement

Financial Statements and Ex...

Financial Results Announcement

Compliance with Minimum Bid...

Agreement and Non-complianc...

Loan Agreement Amendment

Financial Results

Amendment to At the Market ...

Financial Results

Departure of Director, CEO ...

Financial Results

External Links:

On September 12, 2025, Ekso Bionics Holdings, Inc. entered a $2 million secured loan agreement with B. Riley Commercial Capital, primarily for working capital, maturing on September 14, 2026. This agreement replaces a prior loan, enhancing financial flexibility for the company.

AI Assistant

EKSO BIONICS HOLDINGS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.